CACNA1E in cancer diagnosis, detection and treatment

Details for Australian Patent Application No. 2006235276 (hide)

Owner Novartis Vaccines and Diagnostics Inc. Sagres Discovery, Inc.

Inventors Rowe, Michael; Tse, Christin; Yu, Guoying; Xu, Xie; Moler, Edward

Agent FB Rice

Pub. Number AU-A-2006235276

PCT Pub. Number WO2006/110599

Priority 60/669,859 07.04.05 US

Filing date 7 April 2006

Wipo publication date 19 October 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110599 Priority application(s): WO2006/110599

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235279-X-ray tubehead housing with slantangle partition

2006235273-Method and apparatus for dispensing a predetermined fixed amount of prestretched film relative to load girth